Gara Jalqabaatti › Saree (Gosoota Hunda) › Massachusetts

Qorannoo klinikaalii Saree (Gosoota Hunda) Massachusetts keessatti

Qorannoo 95 Saree (Gosoota Hunda) f Massachusetts keessatti hirmaatuu jiru.

Magaalota Massachusetts keessatti

Takkalaa qorannoo (Ingiliffa)

PediRISE Feasibility

Boston Children's Hospital, Boston
Dana Farber Cancer Institute, Boston

Namoota walitti qabaa jira

Hanga umuriin 17 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06283251

Distance-Based Exercise to Preserve Function and Prevent Disability

Dana-Farber Cancer Institute, Boston

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07059884

A Study of ASP3082 in Adults With Advanced Solid Tumors

Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05382559

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Beth Israel Deaconess Medical Center - Research, Boston

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07192471

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

Massachusetts General Hospital, Boston

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07578571

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Boston

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07127874

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Mass General Brigham, Boston
Brigham and Women's Hospital, Boston

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT05874921

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Investigative Site, Boston

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06881992

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Dana Farber Cancer Center ( Site 4013), Boston

Namoota walitti qabaa jiraSadarkaa 1/2

1 Month – 17 Years · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07630974

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Reliant Medical Group Inc, Worcester

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05920356

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Dana Farber/Harvard Cancer Center, Boston
University of Massachusetts - UMass Chan Medical School, Worcester

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06901531

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

Massachusetts General Hospital, Boston

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06910969

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Dana-Farber Cancer Institute /ID# 279690, Boston

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07365241

Pan Tumor Rollover Study

Dana_Farber Cancer Institute (DFCI), Boston

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT03899155

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

Beth Israel Deaconess Medical Center ( Site 0107), Boston
Dana-Farber Cancer Institute ( Site 0105), Boston

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07405164

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Dana Farber Cancer Institute, Boston

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06128551

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Massachusetts General Hospital / Dana-Farber Cancer Institute, Boston
University of Massachusetts Memorial Medical Center, North Worcester

Namoota walitti qabaa jiraSadarkaa 2/3

Umuriin hundi · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Dana-Farber Cancer Institute ( Site 3013), Boston

Namoota walitti qabaa jiraSadarkaa 1/2

1 Month – 17 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06941272

ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs

Dana-Farber Cancer Institute, Boston

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07232043

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

VA Boston Jamaica Plains Campus, West Roxbury

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT05796375

Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Namoota walitti qabaa jira

Hanga umuriin 18 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06609473

Statins to Prevent Cancer Associated Blood Clots

Beth Isreal Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07303816

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Dana-Farber Cancer Institute, Boston

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT04996875

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Dana Farber Cancer Institute, Boston
University of Massachusetts Chan Medical Center, Worcester

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07002034

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Dana-Farber Cancer Institute /ID# 271846, Boston

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06953960

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Boston

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT05123482

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06253871

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Dana-Farber Cancer Institute, Boston

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT05386108

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Boston Medical Center, Boston
Lahey Hospital & Medical Center, Burlington

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06119581

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Dana Farber Cancer Institute, Boston

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06163534

Prostate Active Surveillance Study

Beth Israel Deaconess Medical Center/Harvard Medical School, Boston

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 21 fi ol · Dhiroota · Haaromfame 02-Ful-2026 · NCT00756665

Lurbinectedin in FET-Fused Tumors

Dana-Farber Cancer Institute, Boston

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 10 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT05918640

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Massachusetts General Hospital (MG), Boston

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06983743

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Massachusetts General Hospital, Boston

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07075185

BRIDGE-SIC Efficacy Trial

Brigham and Women's Hospital, Boston
Dana Farber Cancer Institute, Boston

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07735442

Project: Every Child for Younger Patients With Cancer

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston
Baystate Medical Center, Springfield
fi 1 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaa

Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Boston Medical Center, Boston
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT05335928

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Massachusetts General Hospital, Boston

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT04104776

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05919264

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

Beth Israel Deaconess Medical Center, Boston

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06759649

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.